Search Result  ::  Save as CSV :: Back

"Infeksi dengue yang ditularkan melalui gigitan nyamuk Aedes aegypti kepada manusia kerap terjadi di area tropis dan subtropis. Oleh karena manifestasi klinis yang tidak spesifik, berbagai Rapid Diagnostic Tests (RDTs) termasuk SD Bioline Dengue Duo Antigen NS1 dan Antibodi IgM/IgG dibuat untuk memberikan diagnosis dini infeksi dengue yang lebih akurat. Meskipun beberapa studi telah dilakukan untuk menguji sensitifitas dan spesifitas kit tersebut di berbagai negara tetapi informasi mengenai validitasnya dalam mendeteksi keberadaan protein NS1 dari DENV-3 belum dilaksanakan di Indonesia. Pada penelitian ini 105 serum dari pasien yang diduga menderita infeksi dengue diambil dan diuji menggunakan SD Bioline Dengue Duo. Standar baku emas yang digunakan pada penelitian ini adalah RT-PCR dan/atau isolasi virus di sel C6/36 dan atau kenaikan titer antibodi.Hasil penelitian ini menunjukkan rasio deteksi NS1 berbanding terbalik dengan keberadaan antibodi IgM. Sensitivitas, spesifisitas, PPV, dan NPV menunjukkan 81.25%, 100%, 100%, dan 91.89% pada masing-masingnya di awal demam pasien yang terinfeksi DENV-3. Oleh karena itu, SD Bioline Dengue Duo sangat direkomendasikan untuk diagnosis infeksi DENV-3 karena cepat, mudah digunakan, sangat sensitive, spesifik, dan memiliki PPV dan NPV yang tinggi.

---

Dengue infection is transmitted through the bite of Aedes aegypti mosquitoes to human particularly occurs in tropic and subtropic area. Having unspecific spectrum of clinical manifestations, various rapid diagnostic tests (RDTs) including SD Bioline Dengue Duo NS1 antigen and IgM/IgG antibody were made to give early diagnosis of acute dengue infection.

Although several studies have been conducted to examine the sensitivity and spesificity of the kits in various countries, its validity to detect the presence of DENV-3 NS1 antigen has not been held in Indonesia. In total, 105 sera from patients suspected of suffering dengue infection were collected and subjected to SD Bioline Dengue Duo and RT-PCR test as the gold standard.

The result of this study showed NS1 detection rate was inversely proportional to the presence of IgM antibodies. The sensitivity, specificity, PPV, and NPV showed 81.25%, 100%, 100%, and 91.89% respectively at the beginning of fever in DENV-3 infected patients. Thus SD Bioline Dengue Duo is highly recommended for diagnosis of DENV-3 infction as it is rapid, easily applicable, sensitive, highly specific and has great PPV and NPV."

"[ABSTRAKLatar Belakang: Terapi antiretroviral (ARV) terbukti secara efektif dapat menekan replikasi HIV. Pengukuran viral load (VL) merupakan prediktor yang lebih baik dibanding kriteria klinis atau imunologis untuk menilai kegagalan atau keberhasilan terapi ARV. Karena keterbatasan sumber daya, maka pemeriksaan VL tidak selalu mudah untuk diakses oleh pasien HIV yang mendapat terapi ARV sehingga perlu untuk diketahui faktor-faktor pada pasien yang dapat memprediksi terjadinya kegagalan virologis.Tujuan: Mengetahui faktor prediktor kegagalan virologis pada pasien HIV yang mendapat terapi ARV lini pertama sesuai paduan ARV terbaru di Indonesia.Metode: Penelitian ini merupakan studi kohort retrospektif pada pasien HIV rawat jalan dewasa di RSCM yang mulai terapi ARV lini pertama selama periode Januari 2011-Juni 2014. Pasien HIV yang mempunyai data VL 6-9 bulan setelah mulai terapi ARV dengan kepatuhan berobat baik dimasukkan sebagai subjek penelitian. Kegagalan virologis dinyatakan sebagai nilai VL ≥ 400 kopi/mL setelah minimal 6 bulan terapi ARV dengan kepatuhan berobat baik. Paduan ARV yang digunakan terdiri dari dua NNRTI (salah satu dari TDF/AZT/d4T ditambah 3TC) dengan satu NNRTI (NVP atau EFV). Usia, faktor risiko penularan HIV, stadium klinis HIV menurut WHO, ko-infeksi TB, indeks massa tubuh, kadar hemoglobin, dan jumlah CD4 awal terapi serta basis paduan terapi ARV merupakan variabel yang diteliti pada penelitian ini.Hasil: Terdapat 197 pasien sebagai subjek penelitian ini. Kegagalan virologis didapatkan pada 21 pasien (10,7%). Semua variabel yang diteliti belum terbukti dapat memprediksi kegagalan virologis pada pasien HIV yang mendapat terapi ARV lini pertama dengan adherens baik. Terdapat peningkatan risiko kegagalan virologis pada pasien dengan usia yang lebih muda, faktor risiko penasun, stadium klinis lanjut, adanya ko-infeksi TB, dan paduan ARV TDF+3TC+NVP tetapi tidak bermakna secara statistik.!!Simpulan: Dari variabel yang diteliti, tidak didapatkan variabel yang terbukti sebagai prediktor awal kegagalan virologis pada pasien HIV yang mendapat terapi ARV lini pertama dengan adherens baik.

---

ABSTRACTBackground: Antiretroviral therapy (ART) effectively suppress HIV replication. Viral load (VL) measurement is better predictor than clinical or immunological criteria to evaluate failure or success of ART. However, in the country with limited resources, VL measurement is not easily accessible by HIV patients receiving ARV therapy therefore it is necessary to know which factors in the patients that can predict virological failure.Objectives: To know early predictive factor of virological failure in HIV patients receiving recent first line ARV therapy regimen in IndonesiaMethods: This study was a retrospective cohort study among adult HIV patients in Out-patient Clinic of Cipto Mangunkusumo General Hospital that started ARV therapy during periode January 2011-June 2014. HIV patients with good adherence that have VL data 6-9 months after initiation of ARV therapy were included in this study. Virological failure was defined as VL ≥ 400 copies/mL after minimum of 6 months therapy with good adherence. ARV regimen used in this study consist of two NRTI (one of TDF/AZT/d4T plus 3TC) combined with one NNRTI (NVP or EFV). Age, risk factor for HIV infection, HIV clinical stage, HIV- TB co-infection, baseline CD4 value, hemoglobin level, body mass index, and ARV therapy regimen at the time of initiation were among the variables that analyzed in this study.Results: There are 197 patients as subjects in this study. Virological failure was found in 21 patients (10,7%). All the variables included in this study can not predict virological failure in HIV patients receiving first line ART with good adherence. There is increase risk of virological failure in patients with younger age, IDU as risk factor for HIV infection, late clinical stage, TB co-infection, and ARV regimen TDF+3TC+NVP but not reaching statistically significant.Conclusion: There is no variable in this study proved to be early predictive factor for virological failure in HIV patients receiving first line ART with good adherence.;Background: Antiretroviral therapy (ART) effectively suppress HIV replication. Viral load (VL) measurement is better predictor than clinical or immunological criteria to evaluate failure or success of ART. However, in the country with limited resources, VL measurement is not easily accessible by HIV patients receiving ARV therapy therefore it is necessary to know which factors in the patients that can predict virological failure.Objectives: To know early predictive factor of virological failure in HIV patients receiving recent first line ARV therapy regimen in IndonesiaMethods: This study was a retrospective cohort study among adult HIV patients in Out-patient Clinic of Cipto Mangunkusumo General Hospital that started ARV therapy during periode January 2011-June 2014. HIV patients with good adherence that have VL data 6-9 months after initiation of ARV therapy were included in this study. Virological failure was defined as VL ≥ 400 copies/mL after minimum of 6 months therapy with good adherence. ARV regimen used in this study consist of two NRTI (one of TDF/AZT/d4T plus 3TC) combined with one NNRTI (NVP or EFV). Age, risk factor for HIV infection, HIV clinical stage, HIV- TB co-infection, baseline CD4 value, hemoglobin level, body mass index, and ARV therapy regimen at the time of initiation were among the variables that analyzed in this study.Results: There are 197 patients as subjects in this study. Virological failure was found in 21 patients (10,7%). All the variables included in this study can not predict virological failure in HIV patients receiving first line ART with good adherence. There is increase risk of virological failure in patients with younger age, IDU as risk factor for HIV infection, late clinical stage, TB co-infection, and ARV regimen TDF+3TC+NVP but not reaching statistically significant.Conclusion: There is no variable in this study proved to be early predictive factor for virological failure in HIV patients receiving first line ART with good adherence., Background: Antiretroviral therapy (ART) effectively suppress HIV replication. Viral load (VL) measurement is better predictor than clinical or immunological criteria to evaluate failure or success of ART. However, in the country with limited resources, VL measurement is not easily accessible by HIV patients receiving ARV therapy therefore it is necessary to know which factors in the patients that can predict virological failure.Objectives: To know early predictive factor of virological failure in HIV patients receiving recent first line ARV therapy regimen in IndonesiaMethods: This study was a retrospective cohort study among adult HIV patients in Out-patient Clinic of Cipto Mangunkusumo General Hospital that started ARV therapy during periode January 2011-June 2014. HIV patients with good adherence that have VL data 6-9 months after initiation of ARV therapy were included in this study. Virological failure was defined as VL ≥ 400 copies/mL after minimum of 6 months therapy with good adherence. ARV regimen used in this study consist of two NRTI (one of TDF/AZT/d4T plus 3TC) combined with one NNRTI (NVP or EFV). Age, risk factor for HIV infection, HIV clinical stage, HIV- TB co-infection, baseline CD4 value, hemoglobin level, body mass index, and ARV therapy regimen at the time of initiation were among the variables that analyzed in this study.Results: There are 197 patients as subjects in this study. Virological failure was found in 21 patients (10,7%). All the variables included in this study can not predict virological failure in HIV patients receiving first line ART with good adherence. There is increase risk of virological failure in patients with younger age, IDU as risk factor for HIV infection, late clinical stage, TB co-infection, and ARV regimen TDF+3TC+NVP but not reaching statistically significant.Conclusion: There is no variable in this study proved to be early predictive factor for virological failure in HIV patients receiving first line ART with good adherence.]"

"ABSTRAKHuman Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) are serious diseases in the world in which one of transmission methods is through sexual intercourse. This study aimed to explain the influential host factors to the incidence of HIV/AIDS in key populations. The study was conducted in March-September 2016. The study was observational analytic with case-control design in key populations in Pati District. Cases were 53 patients living with HIV/AIDS, while controls were 53 patients not living with HIV/AIDS. The sampling technique employed was consecutive sampling. Data were obtained from medical records and interview questionaire. This study applied chi-square test to analyze bivariate data, and multiple logistic regression to analyze multivariate data. Results indicated that the influential factors to the incidence of HIV/AIDS in key populations were inconsistent condom use behavior, records of suffering from sexually-transmitted infections (STIs), and forms of sexual activity. While, factors which were not influential to the incidence of HIV/AIDS were multiple sex partner behavior, sex accessory use behavior, tattoo needle use behavior, injecting drug use behavior. In conclusion, several influential factors to the incidence of HIV/AIDS in key populations are the inconsistent condom use behavior, records of suffering from STIs, and forms of sexual activity."

"Kejadian keracunan merupakan salah satu masalah kesehatan masyarakat yang penting dalam era transformasi sosial ekonomi, khususnya memasuki era masyarakat industri. Untuk itu telah dilakukan studi korban keracunan pada masyrakat ex Karesidenan Banten, yang dirawat di Rumah Sakit Umum dan Swasta ex Karesidenan Banten, tahun 1907 s/d 1991.Dalam penelitian ini didapatkan 543 kasus keracunan. Dari 8 kelompok/kategori keracunan didapat keracunan tumbuhan (34,07%.) sebagai kategori keracunan terbanyak. Keracunan obat-obatan dan keracunan pestisida merupakan urutan kedua dan ketiga. Perlu dicatat bahwa keracunan pestisida paling banyak untuk tujuan bunuh diri. Terdapat variasi waktu dan tempat dalam kejadian keracunan."